OpGen > Investor Relations > Overview


Corporate Profile

OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. The company’s products and services are designed to enable the rapid identification of hospital patients who are colonized or infected with life-threatening, multi-drug resistant organisms, MDROs.

Upcoming Events

Cowen & Co. 37th Annual Health Care Conference
Monday, March 6, 2017 through Wednesday, March 8, 2017
Wednesday, March 15, 2017 through Friday, March 17, 2017
Saturday, April 22, 2017 through Tuesday, April 25, 2017

More Events

OPGN (Common Stock)
Exchange :NASDAQ CM (US Dollar)
Price :$1.06
Change :0.00 (0.00%)
Volume :0
Data as of 02/17/17 3:54 p.m. ET
Minimum 20 minute delay
Data Provided by Thomson Reuters